Impact of chemotherapy-associated nausea and vomiting on patients' functional status and on costs: survey of five Canadian centres.

B O’Brien(Unknown), Francis Laberge(Ontario Institute for Cancer Research), A. Rocchi, Jean Latreille(Chanel (United Kingdom)), Ted Vandenberg, Shai Fine(Reichman University), James J. Rusthoven(Heidelberg University)

PubMed

August 1, 1993

Cited by 90

Related Papers

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

|Journal of Clinical Oncology|2003|3.1k

Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux Disease

|Medical Decision Making|2002|361

Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux Disease

|Medical Decision Making|2002|321

Symptom Improvement in Lung Cancer Patients Treated With Erlotinib: Quality of Life Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21

|Journal of Clinical Oncology|2006|295

Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods

|Statistical Methods in Medical Research|2002|251